Prognostic Significance of Prehabilitation in Upper Gastro‐Intestinal Cancer Surgery: A Multivariable and Propensity Score Analysis of Outcomes

BACKGROUND: Prehabilitation (prehab) aims to prepare patients for treatment by lowering risk, promoting fitness, and improving outcomes-yet prehab's exact merit is controversial, not least because of conflicting evidence related to study heterogeneity, equity of access, and protocol uniformity. This study aimed to determine prehab's true value in Upper Gastro-Intestinal cancer surgery-the hypothesis was that prehab would reduce Operative Morbidity (OM), shorten Length of Hospital Stay (LoHS) and improve Overall Survival (OS). METHODS: Consecutive patients were studied prospectively, incorporating propensity score analysis. Primary outcomes were OM, mortality, LoHS, costs per Quality-Adjusted Life Years (QALYs) and OS. RESULTS: Consecutive 907 patients undergoing surgery for UGI cancer were included, 182 receiving prehab (median age 67 y, 128 Esophageal Cancer (EC), 54 Gastric Cancer (GC)) and 725 control therapy [67 y, 410 EC, 315 GC]. Prehab OM (Clavien-Dindo ≥ 3) and mortality were 18.1% and 1.6% versus 20.7% (p = 0.179) and 2.5% (p = 0.503) in controls, and median LoHS 11 versus 13 days (p = 0.007). Two-year OS after prehab was 67.9 versus 59.1% in controls (p = 0.027). Multivariable analysis revealed that prehab (HR 0.572, p = 0.012), positive resection margin (HR 1.422, p = 0.003), OM (HR 1.712, p < 0.001) and pTNM stage; complete pathological response p < 0.001, stage II (HR 2.222, p = 0.018), stage III (HR 4.544, p < 0.001) and stage IV (HR 5.926, p < 0.001) were associated with OS. The incremental cost-effectiveness ratio (ICER; additional cost per QALY gained) for prehab was €1292 for EC and €5406 for GC. CONCLUSIONS: Prehab was associated with significant 2-day shorter LoHS and 8.8% better OS, with ICERs well below the NICE willingness-to-pay threshold, supporting the hypothesis that prehab is cost-effective.

Authors

Institutions

Publication Details

Journal
World Journal of Surgery
Published
2026-11-18
DOI
https://doi.org/10.1002/wjs.70600
Primary Topic
Enhanced Recovery After Surgery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prognostic Significance of Prehabilitation in Upper Gastro‐Intestinal Cancer Surgery: A Multivariable and Propensity Score Analysis of Outcomes

Wyn Griffith Lewis, Arfon G. M. T. Powell, Geraint L Herbert, Usman Khalid et al.
3 links
World Journal of Surgery
Enhanced Recovery After Surgery
article

Prognostic Significance of Prehabilitation in Upper Gastro‐Intestinal Cancer Surgery: A Multivariable and Propensity Score Analysis of Outcomes

Wyn Griffith Lewis, Arfon G. M. T. Powell, Geraint L Herbert, Usman Khalid, Rachael Barlow, Tarig Abdelrahman, Donald Fraser, Cardiff Prehabilitation Group
article en

Abstract

BACKGROUND: Prehabilitation (prehab) aims to prepare patients for treatment by lowering risk, promoting fitness, and improving outcomes-yet prehab's exact merit is controversial, not least because of conflicting evidence related to study heterogeneity, equity of access, and protocol uniformity. This study aimed to determine prehab's true value in Upper Gastro-Intestinal cancer surgery-the hypothesis was that prehab would reduce Operative Morbidity (OM), shorten Length of Hospital Stay (LoHS) and improve Overall Survival (OS). METHODS: Consecutive patients were studied prospectively, incorporating propensity score analysis. Primary outcomes were OM, mortality, LoHS, costs per Quality-Adjusted Life Years (QALYs) and OS. RESULTS: Consecutive 907 patients undergoing surgery for UGI cancer were included, 182 receiving prehab (median age 67 y, 128 Esophageal Cancer (EC), 54 Gastric Cancer (GC)) and 725 control therapy [67 y, 410 EC, 315 GC]. Prehab OM (Clavien-Dindo ≥ 3) and mortality were 18.1% and 1.6% versus 20.7% (p = 0.179) and 2.5% (p = 0.503) in controls, and median LoHS 11 versus 13 days (p = 0.007). Two-year OS after prehab was 67.9 versus 59.1% in controls (p = 0.027). Multivariable analysis revealed that prehab (HR 0.572, p = 0.012), positive resection margin (HR 1.422, p = 0.003), OM (HR 1.712, p < 0.001) and pTNM stage; complete pathological response p < 0.001, stage II (HR 2.222, p = 0.018), stage III (HR 4.544, p < 0.001) and stage IV (HR 5.926, p < 0.001) were associated with OS. The incremental cost-effectiveness ratio (ICER; additional cost per QALY gained) for prehab was €1292 for EC and €5406 for GC. CONCLUSIONS: Prehab was associated with significant 2-day shorter LoHS and 8.8% better OS, with ICERs well below the NICE willingness-to-pay threshold, supporting the hypothesis that prehab is cost-effective.

World Journal of Surgery
Manchester Academic Health Science Centre (GB), Royal Gwent Hospital (GB), University Hospital of Wales (GB), Salford Royal NHS Foundation Trust (GB), Morriston Hospital (GB), University of Manchester (GB), Salford Royal Hospital (GB), Northern Care Alliance NHS Foundation Trust (GB), Cardiff University (GB)
Good health and well-being
Enhanced Recovery After Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon